Skip to content
Axcess News – Lifestyle
Author:
Kyverna Therapeutics, Inc.
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
April 9, 2026
Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026
March 7, 2026
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
March 6, 2026
Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
March 5, 2026
←
Previous Page
1
2